These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9082692)

  • 21. [Psychosexual problems in menopause].
    Pisani G; Facioni L; Fiorani F; Pisani G
    Minerva Ginecol; 1998 Mar; 50(3):77-81. PubMed ID: 9595919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gyneco-urologic problems in climacteric].
    Enzelsberger H
    Wien Med Wochenschr; 1992; 142(5-6):115-9. PubMed ID: 1615679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of climacteric symptoms according to years after menopause.
    Sueblinvong T; Taechakraichana N; Phupong V
    J Med Assoc Thai; 2001 Dec; 84(12):1681-91. PubMed ID: 11999814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life impairment during the female menopausal transition is related to personal and partner factors.
    Chedraui P; San Miguel G; Avila C
    Gynecol Endocrinol; 2009 Feb; 25(2):130-5. PubMed ID: 19253110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Official position of the Chilean Society of Climacteric on the management of climacteric women].
    Blümel JE; Aravena H; Brantes S; Cruzat L; Lavín P; Montaño R; Navarrete I; Osorio E
    Rev Med Chil; 2010 May; 138(5):645-51. PubMed ID: 20668822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring climacteric symptoms and age at natural menopause in an Indian population using the Greene Climacteric Scale.
    Kapur P; Sinha B; Pereira BM
    Menopause; 2009; 16(2):378-84. PubMed ID: 19057415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
    Haimov-Kochman R; Barak-Glantz E; Arbel R; Leefsma M; Brzezinski A; Milwidsky A; Hochner-Celnikier D
    Menopause; 2006; 13(3):370-6. PubMed ID: 16735933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
    Carranza-Lira S; Gooch AL; Saldivar N; Osterwalder MS
    Int J Fertil Womens Med; 2007; 52(2-3):93-6. PubMed ID: 18320867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone treatment in the climacteric].
    Siegberg R; Pekonen F
    Nord Med; 1993; 108(10):259-62. PubMed ID: 8414944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The menopausal syndrome.
    Brenner PF
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):6S-11S. PubMed ID: 3050657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of menopausal symptoms--review of the current literature].
    Magyar Z; Fél T
    Orv Hetil; 2006 May; 147(19):879-85. PubMed ID: 16784143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age, pattern of menopause, climacteric symptoms and associated problems among urban population of Hyderabad, Pakistan.
    Qazi RA
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):700-3. PubMed ID: 17052419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new rating scale for the climacteric syndrome (Menopause Rating Scale (MRS)].
    Hauser GA
    Schweiz Med Wochenschr; 1997 Jan; 127(4):122-7. PubMed ID: 9064755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired quality of life among middle aged women: a multicentre Latin American study.
    Chedraui P; Blümel JE; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K
    Maturitas; 2008 Dec; 61(4):323-9. PubMed ID: 19010618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.